Filing Details
- Accession Number:
- 0001374636-11-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-10 16:32:41
- Reporting Period:
- 2011-05-09
- Filing Date:
- 2011-05-10
- Accepted Time:
- 2011-05-10 16:32:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
873364 | Cephalon Inc | CEPH | Pharmaceutical Preparations (2834) | 232484489 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1209727 | D Martyn Greenacre | 41 Moores Road Frazer PA 19355 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-05-09 | 10,000 | $63.98 | 10,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-05-09 | 5,794 | $79.72 | 4,206 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-05-09 | 4,206 | $79.71 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option | Disposition | 2011-05-09 | 10,000 | $0.00 | 10,000 | $63.98 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2005-05-17 | 2011-05-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 200 | Indirect | by Daughter |
Footnotes
- Options vest 25% on each anniversary of grant and are fully vested 4 years from the date of grant. Options expire ten years from date of grant.